Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Back

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Completed

Open to: ALL

Age: 18.0 - N/A

Dundee London Exeter Leicester Nottingham Sheffield Wirral, Merseyside York Cardiff Glasgow Liverpool Bolton Derby Galway London Newcastle Upton

Medical Conditions

Diabetes Mellitus
Diabetes Mellitus, Type 2
Hypoglycemia

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


This trial is conducted in Europe. The aim of this trial is to investigate the difference in frequency of episodes of hypoglycaemia during treatment with biphasic insulin aspart 30 compared to biphasic human insulin 30 in subjects with well controlled type 2 diabetes.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jun 2002 Nov 2003

Publications

"McNally PG, Dean JD, Morris AD, Wilkinson PD, Compion G, Heller SR. Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes. Diabetes Care. 2007 May;30(5):1044-8. doi: 10.2337/dc06-1328. Epub 2007 Feb 2."; "17277042"

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : Administrated s.c. (subcutaneously, under the skin) for 16 weeks in treatment period 1 followed by 16 weeks in treatment period 2

Intervention Arm Group : Treatment period 1;Treatment period 2;

Intervention Type : DRUG
Intervention Description : Administrated s.c. (subcutaneously, under the skin) for 16 weeks in treatment period 1 followed by 16 weeks in treatment period 2

Intervention Arm Group : Treatment period 1;Treatment period 2;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Novo Nordisk Investigational Site
    Dundee
    DD1 9SY
  • Novo Nordisk Investigational Site
    London
    SE1 7EH
  • Novo Nordisk Investigational Site
    Exeter
    EX2 5AX
  • Novo Nordisk Investigational Site
    Leicester
    LE1 5WW
  • Novo Nordisk Investigational Site
    Nottingham
    NG7 2UH
  • Novo Nordisk Investigational Site
    Sheffield
    S5 7AU
  • Novo Nordisk Investigational Site
    Wirral, Merseyside
    CH63 4JY
  • Novo Nordisk Investigational Site
    York
    YO3 7HE
  • Novo Nordisk Investigational Site
    Cardiff
    CF14 4XW
  • Novo Nordisk Investigational Site
    Glasgow
    G4 0SF
  • Novo Nordisk Investigational Site
    Liverpool
    L7 8XP
  • Novo Nordisk Investigational Site
    Bolton
    BL1 4QS
  • Novo Nordisk Investigational Site
    Derby
    DE7 1DY
  • Novo Nordisk Investigational Site
    Galway
    EIRE
  • Novo Nordisk Investigational Site
    London
    NW10 7NS
  • Novo Nordisk Investigational Site
    Newcastle
    NE7 7DN
  • Novo Nordisk Investigational Site
    Upton
    L49 5PE


The study is sponsored by Novo Nordisk A/S




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT01487798
Last updated 05 January 2017

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top